Stay updated on Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial
Sign up to get notified when there's something new on the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page.

Latest updates to the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays an updated ClinicalTrials.gov interface/revision identifier (from v3.5.2 to v3.5.3) without indicating any changes to the underlying study record details.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the history page.SummaryDifference0.1%

- Check56 days agoChange DetectedThe revision tag was updated to v3.5.0, replacing the previous v3.4.3 entry.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision v3.4.3 was added and the previous revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check92 days agoChange DetectedThe updated page shows a minor revision from v3.4.1 to v3.4.2. No study record data or history entries were altered.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 in the page history, representing a minor UI/version label update. No study data or content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page.